New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

被引：90

作者：

Chen, Lucy F. ^{[1
]}

Cohen, Ezra E. W. ^{[1
]}

Grandis, Jennifer R. ^{[2
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

来源：

CLINICAL CANCER RESEARCH | 2010年 / 16卷 / 09期

关键词：

SQUAMOUS-CELL CARCINOMA; TYROSINE KINASE INHIBITORS; LUNG-CANCER; PLUS CETUXIMAB; CONSTITUTIVE ACTIVATION; MESENCHYMAL TRANSITION; ACQUIRED-RESISTANCE; PHASE-II; IN-SITU; EGFR;

D O I：

10.1158/1078-0432.CCR-09-2318

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The epidermal growth factor receptor (EGFR) is a validated target in squamous cell carcinoma of the head and neck (HNSCC). However, despite high expression of EGFR in these cancers, EGFR inhibitor monotherapy has only had modest activity. Potential mechanisms of resistance to EGFR-targeted therapies involve EGFR and Ras mutations, epithelial-mesenchymal transition, and activation of alternative and downstream pathways. Strategies to optimize EGFR-targeted therapy in head and neck cancer involve not only the selection for patients most likely to benefit but also the use of combination therapies to target the network of pathways involved in tumor growth, invasion, angiogenesis, and metastasis. Clin Cancer Res; 16(9); 2489-95. (C) 2010 AACR.

引用

页码：2489 / 2495

页数：7

共 60 条

[1] An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors [J].

Amador, ML ;

Oppenheimer, D ;

Perea, S ;

Maitra, A ;

Cusati, G ;

Iacobuzio-Donahue, C ;

Baker, SD ;

Ashfaq, R ;

Takimoto, C ;

Forastiere, A ;

Hidalgo, M .

CANCER RESEARCH, 2004, 64 (24) :9139-9143

[2]

ANDERSON JA, 1994, ARCH OTOLARYNGOL, V120, P755

[3]

ARGIRIS A, 2009, J CLIN ONCOL S, V27, pS15

[4] Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells [J].

Azzariti, Amalia ;

Porcelli, Letizia ;

Gatti, Giuliana ;

Nicolin, Angelo ;

Paradiso, Angelo .

BIOCHEMICAL PHARMACOLOGY, 2008, 75 (05) :1035-1044

[5] HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells [J].

Bachleitner-Hofmann, Thomas ;

Sun, Mark Y. ;

Chen, Chin-Tung ;

Tang, Laura ;

Song, Lin ;

Zeng, Zhaoshi ;

Shah, Manish ;

Christensen, James G. ;

Rosen, Neal ;

Solit, David B. ;

Weiser, Martin R. .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) :3499-3508

[6] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[7]

Bonner JA, 2000, J CLIN ONCOL, V18, p47S

[8] Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck [J].

Bourhis, Jean ;

Rivera, Fernando ;

Mesia, Ricard ;

Awada, Ahmad ;

Geoffrois, Lionel ;

Borel, Christian ;

Humblet, Yves ;

Lopez-Pousa, Antonio ;

Hitt, Ricardo ;

Vega Villegas, M. Eugenia ;

Duck, Lionel ;

Rosine, Dominique ;

Amellal, Nadia ;

Schueler, Armin ;

Harstrick, Andreas .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2866-2872

[9] Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors [J].

Buck, Elizabeth ;

Eyzaguirre, Alexandra ;

Rosenfeld-Franklin, Maryland ;

Thomson, Stuart ;

Mulvihill, Mark ;

Barr, Sharon ;

Brown, Eric ;

O'Connor, Mathew ;

Yao, Yan ;

Pachter, Jonathan ;

Miglarese, Mark ;

Epstein, David ;

Iwata, Kenneth K. ;

Haley, John D. ;

Gibson, Neil W. ;

Ji, Qun-Sheng .

CANCER RESEARCH, 2008, 68 (20) :8322-8332

[10] Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study [J].

Burtness, B ;

Goldwasser, MA ;

Flood, W ;

Mattar, B ;

Forastiere, AA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8646-8654

← 1 2 3 4 5 6 →